KRAS Testing and Epidermal Growth Factor Receptor Inhibitor Treatment for Colorectal Cancer in Community Settings

BACKGROUND: In metastatic colorectal cancer (mCRC), mutations in the KRAS gene predict poor response to epidermal growth factor receptor (EGFR) inhibitors. Clinical treatment guidelines now recommend KRAS testing if EGFR inhibitors are considered. Our study investigates the clinical uptake and utili...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Webster, Jennifer, Kauffman, Tia L., Feigelson, Heather Spencer, Pawloski, Pamala A., Onitilo, Adedayo A., Potosky, Arnold L., Cross, Deanna, Meier, Paul R., Mirabedi, Anousheh S., Delate, Thomas, Daida, Yihe, Williams, Andrew E., Alexander, Gwen L., McCarty, Catherine A., Honda, Stacey, Kushi, Lawrence H., Goddard, Katrina A.B.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3567775/
https://ncbi.nlm.nih.gov/pubmed/23155138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-12-0545
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados